Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Sudden Cardiac Death, Bradycardia
Interventions: AV Therapy Assessment-B301 investigational device; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 36
States / cities: Anchorage, Alaska • Larkspur, California • Orlando, Florida + 32 more

Conditions: PHYSIOLOGICAL PHENOMENA, Homeostasis, Physical Functional Performance, Cardiorespiratory Fitness, Cardiometabolic Risk Factors, Mobility Limitation
Interventions: Standardized Physiologic Resilience Challenge, Multimodal Whole-Body Physiologic Monitoring, Research-Only Whole-Body Digital Twin Analysis; Procedure · Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2041
U.S. locations: 1
States / cities: New York, New York

Conditions: LVAD (Left Ventricular Assist Device) Thrombosis, Heart Failure, Bleeding, Thrombosis; Artery, Stroke, Heart Transplant
Interventions: Warfarin, Apixaban; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Cerebral Aneurysms
Interventions: Contour Neurovascular System Treatment Attempt; Device
Lead sponsor: Cerus Endovascular, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 9
States / cities: Park Ridge, Illinois • Kansas City, Kansas • Buffalo, New York + 5 more

Conditions: Organic Erectile Dysfunction
Interventions: Viberect; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 30 Years to 70 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland • Frederick, Maryland

Conditions: Lumbar Spinal Stenosis
Interventions: Interspinous Fusion; Device
Lead sponsor: Pacific Research Institute; Network
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 10
States / cities: Santa Rosa, California • Jupiter, Florida • Slidell, Louisiana + 6 more

Conditions: Recurrent Head and Neck Squamous Cell Carcinoma
Interventions: ASP-1929 Photoimmunotherapy, Pembrolizumab, Carboplatin, Cisplatin, 5-fluorouracil, Paclitaxel, Docetaxel; Combination Product · Biological · Drug
Lead sponsor: Rakuten Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 8
States / cities: Duarte, California • Miami, Florida • Tampa, Florida + 5 more

Conditions: Skin Resurfacing
Interventions: OPUS system; Device
Lead sponsor: Alma Lasers; Industry
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Wrinkle, Fine Lines, Crepey Skin, Acne Scars, Active Acne, Enlarged Pores, Stretch Mark, Loose Skin
Interventions: RadioFrequency Microneedling Device; Device
Lead sponsor: Cynosure, Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Westford, Massachusetts

Conditions: Acute Low-back Pain, Chronic Low-back Pain, Pain, Intractable
Interventions: Duotherm VibraCool Back Device, TENS 8-channel unit; Device
Lead sponsor: MMJ Labs LLC; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Landover, Maryland • Fairfax, Virginia

Conditions: Cough, Reflux
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Kidney Injury, Heart Failure
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Sleep Quality
Interventions: OOLER, EmbrWave; Other
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Patient Transport, Respiratory Failure, Noninvasive Ventilation, High-Flow Nasal Oxygen, Mechanical Ventilation, Patient Safety, Transport Safety, Medical Equipment Safety, Electrical Power Continuity
Interventions: Portable External Power Supply; Device
Lead sponsor: Medipol University; Other
Eligibility: Not listed
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Mount Kisco, New York

Conditions: Carotid Artery Stenosis
Interventions: FiberNet Emboli Protection System; Device
Lead sponsor: Lumen Biomedical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 4
States / cities: Newport Beach, California • Takoma Park, Maryland • Columbus, Ohio + 1 more

Conditions: Pelvic Fractures, Acetabular Fractures, Hip Fractures
Interventions: VAC device, Gauze dressing; Device · Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Obstructive Sleep Apnea Hypopnea, Obstructive Sleep Apnea, OSAH
Interventions: Not listed
Lead sponsor: Ventus Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 13
States / cities: Wallingford, Connecticut • Gainesville, Florida • Atlanta, Georgia + 10 more

Conditions: Parkinson Disease Dementia
Interventions: Non-invasive brainstem stimulation; Device
Lead sponsor: Scion NeuroStim; Industry
Eligibility: 50 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Boca Raton, Florida • Kansas City, Kansas

Conditions: Total Knee Arthroplasty
Interventions: iovera°; Device
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 22 Years to 79 Years
Enrollment: 124 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Germantown, Tennessee

Conditions: Graves Disease, Hyperthyroidism/Thyrotoxicosis
Interventions: Heart rate-based AI software for detecting thyrotoxicosis; Device
Lead sponsor: THYROSCOPE INC.; Industry
Eligibility: 22 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Endocrine System Diseases
Interventions: Metformin, Questionnaires; Drug · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Incisions, Surgical
Interventions: NP-PWD; Device
Lead sponsor: The Metis Foundation; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Ambulation Difficulty, Lower Extremity Problem
Interventions: Gigstride Ambulatory Device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Urinary Urge Incontinence, Stress Urinary Incontinence, Prostatic Hyperplasia
Interventions: Elidah Device; Device
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years · Male only
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

REASSURE AV Registry

Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)

SWITCH: Apixaban vs Vitamin K in HM3

Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate ED

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study

Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions

Impact of DuoTherm Compared to TENS on Pain and Disability With Acute and Chronic Low Back Pain

Cough Monitoring Study

Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

Efficacy of Commercially Available Technology in Augmenting Sleep and Well-being

HERMES: International Survey and Portable External Power Evaluation During Respiratory Support Transport

EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures

Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea

SHARPEN - Parkinson's Disease Dementia

Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain

Evaluating an AI Tool for Detecting Thyrotoxic States

Diabetic Treatment Adherence

A Case Series Study of Negative Pressure Platform Wound Device

Use Of Gigstride Device In Patients With Lower Extremity Deficit

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer